AUG 21, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Claravis (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval of labeling for an established isotretinoin product; this is a regulatory action, not a clinical trial, and does not report efficacy or safety data.
Reported
Approval date2026-08-21
Product strengthISOTRETINOIN 10MG